Strengthening Surveillance in Jurisdictions with High Incidence of Hepatitis C Virus and Hepatitis B Virus Infections (CDC-RFA-PS17-1703)
Period Length: 4 Years
Funds provided through this cooperative agreement will be used to enable jurisdictions experiencing high rates of new cases of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infections to engage directly with providers, laboratories, and patients to obtain more complete case information. These statewide viral hepatitis surveillance data will be used to determine and document the burden of disease; identify outbreaks; identify groups that are at high risk of transmitting and/or acquiring the infections; and, support design, implementation, and evaluation of prevention services including testing, linkage to care, and treatment. CDC is funding surveillance projects in 14 states:
- New Jersey
- North Carolina
- West Virginia
Funding for the four-year project period is expected to be approximately $3.2M each year.